海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Study of the effect of novel analogues of insulin in people with type 1 diabetes
- DIABETES TYPE 1 MedDRA version: 19.0 Level: PT Classification code 10022491 Term: Insulin resistant diabetes System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]
- Spain
- 2016-08-25
Authorised
- Sunitinib in the treatment of metastatic Pheochromocytomas/Paragangliomas
- Patients with unresectable and/or metastatic pheochromocytomas/paragangliomas br>MedDRA version: 14.1 Level: LLT Classification code 10001375 Term: Adrenal neoplasm NOS System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Italy
- 2012-03-07
Authorised
- Plasma sostitution in paediatric neurosurgery: comparison between two sinthetic colloids: HES 130/0,42/6:1 in normal salin solution (Voluven)vs HES 130/0,42/6:1 in balanced electrolitic solution (plasmavolume)
- pediatric patients undergoing major neurosurgical procedures MedDRA version: 14.1 Level: SOC Classification code 10029205 Term: Nervous system disorders System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Italy
- 2012-03-02
Authorised
- Phase 3a study to evaluate the efficacy and safety of 4-week treatment of the axillary skin with 1% GPB cream vs placebo and open-label Phase 3b study to assess long-term efficacy and safety in patients with primary axillary hyperhidrosis treated with 1% GPB cream
- Moderate to severe primary axillary hyperhidrosis MedDRA version: 20.0 Level: PT Classification code 10020642 Term: Hyperhidrosis System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Austria, Denmark, Germany, Hungary, Poland, Sweden, United Kingdom
- 2018-06-20
Authorised
- FIBRINOGEN AND BLEEDING AFTER CARDIAC SURGERY
- 60 patients undergoing coronary artery bypass surgery MedDRA version: 9.1 Level: LLT Classification code 10011077 Term: Coronary artery bypass
- Sweden
- 2008-02-22
Authorised
- Tyrosine kinase Inhibitors in DysplAsia of Lung epithelium Study 1 - TIDAL 1 Version 1.0
- High grade dysplasia of the bronchoepithelium MedDRA version: 13.1 Level: PT Classification code 10057004 Term: Bronchial dysplasia System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
- United Kingdom
- 2011-04-27
Authorised
- "Ensayo clínico piloto, unicéntrico, controlado con placebo, a doble-ciego, aleatorio y cruzado con alfa-1-antitripsina humana en sujetos con fibromialgia". "A single-centre, randomised, double-blind, controlled with placebo, cross-over, pilot clinical trial with human alpha-1-antitrypsin in subjects with fibromyalgia".
- Tratamiento sintomático de la fibromialgia Sintomatic treatment of fibromyalgia MedDRA version: 8.1 Level: LLT Classification code 10048439 Term: Fibromyalgia
- Spain
- 2006-06-28
Authorised
- Effect on metabolic acidosis due to hyperammonemia of high versus low intake of amino acid in VLBW infants.
- At birth, a VLBW infant is abruptly disconnected from the ideal source of parenteral nutrition - the placenta. If the goal of post-natal nutrition in the VLBW infant is to mimic in utero nutrition. The VLBW infant should be immediately placed on balanced parenteral nutrition. In current praxis parenteral nutrition used to be delayed for several days. MedDRA version: 9.1 Level: LLT Classification code 10063258 Term: Amino acid level
- Germany
- 2007-04-23
Authorised
- Título completo del ensayo: Estudio fase II de utilización de células dendríticas mieloides autólogas como adyuvante celular para una vacuna terapéutica contra el virus de la inmunodeficiencia tipo 1 en pacientes en estadíos tempranos de la infección por VIH-1.
- Infección por virus de la inmunodeficiencia humana
- Spain
- 2005-10-11
Authorised
- Phase 3a study to evaluate the efficacy and safety of 4-week treatment of the axillary skin with 1% GPB cream vs placebo and open-label Phase 3b study to assess long-term efficacy and safety in patients with primary axillary hyperhidrosis treated with 1% GPB cream
- Moderate to severe primary axillary hyperhidrosis MedDRA version: 20.0 Level: PT Classification code 10020642 Term: Hyperhidrosis System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Austria, Denmark, Germany, Hungary, Poland, Sweden, United Kingdom
- 2018-09-27
